As of today (2024-04-24), AVITA Medical's share price is $8.57. AVITA Medical's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $1.89. Hence, AVITA Medical's Price to Tangible Book Ratio of today is 4.53.
The historical rank and industry rank for AVITA Medical's Price-to-Tangible-Book or its related term are showing as below:
RCEL'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.97 Med: 29.59 Max: 140.68
Current: 4.53
During the past 13 years, AVITA Medical's highest Price to Tangible Book Ratio was 140.68. The lowest was 1.97. And the median was 29.59.
RCEL's Price-to-Tangible-Book is ranked worse than 67.09% of 702
companies
in the Medical Devices & Instruments industry
Industry Median: 2.62
vs RCEL: 4.53
A closely related ratio is called PB Ratio. As of today, AVITA Medical's share price is $8.57. AVITA Medical's Book Value per Sharefor the quarter that ended in Dec. 2023 was $1.91. Hence, AVITA Medical's P/B Ratio of today is 4.49.
AVITA Medical Price-to-Tangible-Book Historical Data
The historical data trend for AVITA Medical's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of AVITA Medical's Price-to-Tangible-Book
For the Medical Devices subindustry, AVITA Medical's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AVITA Medical's Price-to-Tangible-Book Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AVITA Medical's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where AVITA Medical's Price-to-Tangible-Book falls into.
AVITA Medical Price-to-Tangible-Book Calculation
AVITA Medical's price-to-tangible-book ratio for today is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
AVITA Medical Price-to-Tangible-Book Related Terms
Thank you for viewing the detailed overview of AVITA Medical's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
AVITA Medical (AVITA Medical) Business Description
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the U.S. with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 U.S. burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the U.S. region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the U.S.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
RCEL has been successfully added to your 